Prognostic and Predictive Value of Three DNA Methylation Signatures in Lung Adenocarcinoma
暂无分享,去创建一个
Run Shi | Xuanwen Bao | Haowen Deng | Yanfang Wang | Kai Zhang | Shan Xin
[1] P. Vineis,et al. DNA methylation and associated gene expression in blood prior to lung cancer diagnosis in the Norwegian Women and Cancer cohort , 2018, Scientific Reports.
[2] A. Jemal,et al. Higher Lung Cancer Incidence in Young Women Than Young Men in the United States , 2018, The New England journal of medicine.
[3] Lianghong Zheng,et al. DNA methylation markers for diagnosis and prognosis of common cancers , 2017, Proceedings of the National Academy of Sciences.
[4] Jonathan A. Heiss,et al. DNA methylation signatures in peripheral blood strongly predict all-cause mortality , 2017, Nature Communications.
[5] T. VanderWeele,et al. Review Article: The Role of Molecular Pathological Epidemiology in the Study of Neoplastic and Non-neoplastic Diseases in the Era of Precision Medicine , 2016, Epidemiology.
[6] Howard Cedar,et al. DNA Methylation in Cancer and Aging. , 2016, Cancer research.
[7] Liang Cheng,et al. Relapse-related long non-coding RNA signature to improve prognosis prediction of lung adenocarcinoma , 2016, Oncotarget.
[8] Antoni Rosell,et al. A Novel Epigenetic Signature for Early Diagnosis in Lung Cancer , 2016, Clinical Cancer Research.
[9] Vessela Kristensen,et al. Genome‐wide DNA methylation analyses in lung adenocarcinomas: Association with EGFR, KRAS and TP53 mutation status, gene expression and prognosis , 2015, Molecular oncology.
[10] Maite Huarte. The emerging role of lncRNAs in cancer , 2015, Nature Medicine.
[11] J. Alcaraz,et al. Aberrant DNA methylation in non-small cell lung cancer-associated fibroblasts , 2015, Carcinogenesis.
[12] D. Patel,et al. DNA methylation pathways and their crosstalk with histone methylation , 2015, Nature Reviews Molecular Cell Biology.
[13] Myeong Sup Lee,et al. Reducing DNA methylation suppresses colon carcinogenesis by inducing tumor cell differentiation. , 2015, Carcinogenesis.
[14] John T. Poirier,et al. DNA methylation in small cell lung cancer defines distinct disease subtypes and correlates with high expression of EZH2 , 2015 .
[15] D. Schübeler. Function and information content of DNA methylation , 2015, Nature.
[16] X. Ni,et al. ROS-mediated DNA methylation pattern alterations in carcinogenesis. , 2015, Current drug targets.
[17] Steven J. M. Jones,et al. Comprehensive molecular profiling of lung adenocarcinoma , 2014, Nature.
[18] Xuelian Li,et al. An eight-miRNA signature as a potential biomarker for predicting survival in lung adenocarcinoma , 2014, Journal of Translational Medicine.
[19] Jian Lu,et al. Prognostic and predictive value of a microRNA signature in stage II colon cancer: a microRNA expression analysis. , 2013, The Lancet. Oncology.
[20] M. Esteller,et al. A prognostic DNA methylation signature for stage I non-small-cell lung cancer. , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[21] T. Mok,et al. Epigenomic analysis of lung adenocarcinoma reveals novel DNA methylation patterns associated with smoking , 2013, OncoTargets and therapy.
[22] D. Haussler,et al. Exploring TCGA Pan-Cancer Data at the UCSC Cancer Genomics Browser , 2013, Scientific Reports.
[23] M. Esteller,et al. Genome-wide DNA methylation profiling predicts relapse in childhood B-cell acute lymphoblastic leukaemia , 2012, British journal of haematology.
[24] S. Lam,et al. Genome-scale analysis of DNA methylation in lung adenocarcinoma and integration with mRNA expression , 2012, Genome research.
[25] Peter A. Jones. Functions of DNA methylation: islands, start sites, gene bodies and beyond , 2012, Nature Reviews Genetics.
[26] K. Polyak,et al. Intra-tumour heterogeneity: a looking glass for cancer? , 2012, Nature Reviews Cancer.
[27] Charles A Powell,et al. International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society: international multidisciplinary classification of lung adenocarcinoma: executive summary. , 2011, Proceedings of the American Thoracic Society.
[28] D. Spiegelhalter,et al. Associations Between Fine Particulate Matter Components and Daily Mortality in Nagoya, Japan , 2015, Journal of epidemiology.
[29] Masahiro Tsuboi,et al. International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary Classification of Lung Adenocarcinoma , 2011, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.
[30] P Giraud,et al. Chapter 44 – Non–Small Cell Lung Cancer , 2016 .
[31] S. Horvath,et al. Global levels of histone modifications predict prognosis in different cancers. , 2009, The American journal of pathology.
[32] T. Carey,et al. Galanin Receptor Subtype 2 Suppresses Cell Proliferation and Induces Apoptosis in p53 Mutant Head and Neck Cancer Cells , 2009, Clinical Cancer Research.
[33] Takayuki Kosaka,et al. Prognostic Implication of EGFR, KRAS, and TP53 Gene Mutations in a Large Cohort of Japanese Patients with Surgically Treated Lung Adenocarcinoma , 2009, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.
[34] Y. Ohe,et al. EGFR mutations predict survival benefit from gefitinib in patients with advanced lung adenocarcinoma: a historical comparison of patients treated before and after gefitinib approval in Japan. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[35] Thomas E. Carey,et al. Epigenetic Inactivation of Galanin Receptor 1 in Head and Neck Cancer , 2008, Clinical Cancer Research.
[36] A. Georgakilas,et al. Oxidative stress, DNA methylation and carcinogenesis. , 2008, Cancer letters.
[37] Mihaela Campan,et al. Identification of a panel of sensitive and specific DNA methylation markers for squamous cell lung cancer , 2008, Molecular Cancer.
[38] Wendy Cozen,et al. Identification of a panel of sensitive and specific DNA methylation markers for lung adenocarcinoma , 2007, Molecular Cancer.
[39] Quynh-Thu Le,et al. Non-small cell lung cancer: Clinical practice guidelines in oncology , 2006 .
[40] H. Koong,et al. Never-smokers with lung cancer: epidemiologic evidence of a distinct disease entity. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[41] Renato Martins,et al. Non-small cell lung cancer. , 2012, Journal of the National Comprehensive Cancer Network : JNCCN.
[42] David E. Misek,et al. Gene-expression profiles predict survival of patients with lung adenocarcinoma , 2002, Nature Medicine.
[43] I. Weissman,et al. Stem cells, cancer, and cancer stem cells , 2001, Nature.
[44] B. Hankey,et al. The surveillance, epidemiology, and end results program: a national resource. , 1999, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[45] S Ramchandani,et al. DNA methylation is a reversible biological signal. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[46] J. Herman,et al. Inactivation of the CDKN2/p16/MTS1 gene is frequently associated with aberrant DNA methylation in all common human cancers. , 1995, Cancer research.